Literature DB >> 10989896

Recurrent nerve nodal involvement is associated with cervical nodal metastasis in thoracic esophageal carcinoma.

Y Tabira1, M Yasunaga, M Tanaka, K Nakano, T Sakaguchi, N Nagamoto, S Ogi, N Kitamura.   

Abstract

BACKGROUND: Because three-field dissection for esophageal carcinoma is one of the most invasive operations, this procedure should be selected only when strictly indicated; but there are no useful criteria for it. The goal of this study was to identify the useful clinicopathologic factors for indicating three-field dissection. STUDY
DESIGN: In this study, we reviewed the survival of patients after three-field dissection and identified factors associated with metastases in cervical nodes (CN), especially internal jugular nodes and supraclavicular nodes. Eighty-six patients who underwent curative esophagectomy with three-field dissection for squamous cell carcinoma of the thoracic esophagus were enrolled in this study. Survival rates were compared with respect to the presence of nodal metastasis. The relationship between recurrent nerve nodal (RNN) involvement and CN metastasis (bilateral internal jugular nodes, supraclavicular nodes, or both) was examined. Clinicopathologic factors possibly influencing CN metastasis were studied by multivariate logistic regression analysis.
RESULTS: The overall 5-year survival rate was 45.1%. The 5-year survival rate for patients without metastatic nodes was 67.5%, for patients with one to four metastatic nodes it was 53.1%, and for patients with five or more it was 9.1 %. The prognosis of those with five or more metastatic nodes was significantly poorer than those of the other two groups. In the positive-node group, the 5-year survival rate for patients with RNN metastasis was 21.7%, and for patients with negative RNN it was 47.0% (p = 0.2). In the positive-node group, the 5-year survival rate for patients with positive CN was 13.7% and for patients with negative CN it was 45.8% (p = 0.01). Fifty-six (88.9%) of 63 patients without RNN metastasis had no CN metastasis in contrast to 13 of 23 patients (56.5%) with RNN metastasis who had no CN metastasis (p = 0.001). The positive predictive value, negative predictive value, sensitivity, and specificity were 43.5%, 88.8%, 58.8%, and 81.2%, respectively. The number of metastatic nodes (5 or more versus 0-4) (odds ratio: 2.9, 95% Confidence Interval (CI) = 1.6-5.5, p = 0.0008) and RNN involvement (odds ratio: 4.5, 95% CI = 1.3-15.9, p = 0.02) were the significant factors associated with CN metastasis in the multivariate analysis.
CONCLUSIONS: RNN involvement is associated with CN metastasis as is the number of metastatic nodes and may be an indicator for the selection of three-field dissection in thoracic esophageal carcinoma.

Entities:  

Mesh:

Year:  2000        PMID: 10989896     DOI: 10.1016/s1072-7515(00)00348-3

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  22 in total

Review 1.  Current management of esophageal cancer.

Authors:  Simon Law; John Wong
Journal:  J Gastrointest Surg       Date:  2005-02       Impact factor: 3.452

2.  Anatomy of right recurrent nerve node: why does early metastasis of esophageal cancer occur in it?

Authors:  Masaomi Mizutani; Gen Murakami; Shin-Ichi Nawata; Ichiro Hitrai; Wataru Kimura
Journal:  Surg Radiol Anat       Date:  2006-05-23       Impact factor: 1.246

3.  Effect of bilateral supraclavicular postoperative radiotherapy in middle and lower thoracic esophageal carcinoma.

Authors:  Yi Ren; Chang Su; Yang Zhou; Xiang Zhao; Cheng-Liang Yang; Yong-Yu Liu
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

4.  Clinical course and outcome after esophagectomy with three-field lymphadenectomy in esophageal cancer.

Authors:  Shoji Natsugoe; Masataka Matsumoto; Hiroshi Okumura; Yasuto Uchikado; Tetsuro Setoyama; Ken Sasaki; Toshihide Sakurai; Itaru Omoto; Tetsuhiro Owaki; Hiroyuki Shinchi; Shinichi Ueno; Sumiya Ishigami
Journal:  Langenbecks Arch Surg       Date:  2010-02-21       Impact factor: 3.445

Review 5.  Three-field vs two-field lymph node dissection for esophageal cancer: a meta-analysis.

Authors:  Guo-Wei Ma; Dong-Rong Situ; Qi-Long Ma; Hao Long; Lan-Jun Zhang; Peng Lin; Tie-Hua Rong
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

6.  Association of the primary tumor location with the site of tumor recurrence after curative resection of thoracic esophageal carcinoma.

Authors:  Yuichiro Doki; Osamu Ishikawa; Ko Takachi; Isao Miyashiro; Yo Sasaki; Hiroaki Ohigashi; Kohei Murata; Terumasa Yamada; Shingo Noura; Hidetoshi Eguchi; Toshiyuki Kabuto; Shingi Imaoka
Journal:  World J Surg       Date:  2005-06       Impact factor: 3.352

7.  Aggressive surgical resection does not improve survival in operable esophageal squamous cell carcinoma with N2-3 status.

Authors:  Yu-Zhen Zheng; Wei Zhao; Yi Hu; Xiao-Xiao Ding-Lin; Jing Wen; Hong Yang; Qian-Wen Liu; Kong-Jia Luo; Qing-Yuan Huang; Jun-Ying Chen; Jian-Hua Fu
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

8.  Postoperative gastrointestinal dysfunction after 2-field versus 3-field lymph node dissection in patients with esophageal cancer.

Authors:  Misuzu Nakamura; Yoshihiro Kido; Yoshinori Hosoya; Masahiko Yano; Hideo Nagai; Morito Monden
Journal:  Surg Today       Date:  2007-04-30       Impact factor: 2.549

9.  Improved survival for patients with upper and/or middle mediastinal lymph node metastasis of squamous cell carcinoma of the lower thoracic esophagus treated with 3-field dissection.

Authors:  Hiroyasu Igaki; Yuji Tachimori; Hoichi Kato
Journal:  Ann Surg       Date:  2004-04       Impact factor: 12.969

Review 10.  Lymphatic spreading and lymphadenectomy for esophageal carcinoma.

Authors:  Xiang Ji; Jie Cai; Yao Chen; Long-Qi Chen
Journal:  World J Gastrointest Surg       Date:  2016-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.